Symptom Management Neutropenia Pain and Nutrition Case Lab

Case Lab: Neutropenia, Pain, and Nutrition

Case Snapshot

A 59-year-old on dose-dense chemotherapy calls at 7 PM with temperature 38.4 C, chills, sore throat, and fatigue. The same patient has metastatic bone pain rated 8/10 despite short-acting opioids and has lost 8% of body weight in two months because food tastes metallic. One case crosses infection risk, pain, nutrition, medication safety, and education.

Neutropenic Fever

Febrile neutropenia is defined (IDSA) as a single oral temperature >=38.3 C (101 F) or >=38.0 C (100.4 F) sustained over one hour, with an absolute neutrophil count (ANC) <500 cells/mm3 (or expected to fall below 500 within 48 hours). It is an oncologic emergency because the inflammatory response is blunted and infection progresses rapidly. The standard of care is to draw blood cultures (peripheral and each lumen of any central line) and start broad-spectrum IV antibiotics, such as an antipseudomonal beta-lactam (cefepime, piperacillin-tazobactam, or a carbapenem), within one hour of presentation.

This 38.4 C patient meets the fever threshold after myelosuppressive therapy and must be told to come in now, not to take acetaminophen and call in the morning. Acetaminophen masks fever and delays recognition. Assess temperature method, timing, chills, localizing symptoms, last chemotherapy date, central line, prophylaxis, allergies, and safe transport, then direct immediate evaluation per protocol and notify the provider.

Teach before neutropenia: monitor temperature, when to call, avoid rectal temperatures/suppositories/enemas, hand hygiene, neutropenic food safety (no raw/undercooked foods, washed produce, no unpasteurized items), central-line care, vaccination timing with oncology, and avoiding crowds and sick contacts. Absence of fever does not make severe symptoms safe.

Cancer Pain

Pain assessment is functional and cause-oriented: location, intensity, quality, onset, aggravating/relieving factors, effect on sleep and function, neurologic symptoms, bowel function, sedation, falls, current regimen, last dose, adherence barriers, and patient goals. New back pain with weakness, numbness, or bowel/bladder change is not routine pain and may signal spinal cord compression requiring emergency escalation.

For persistent 8/10 metastatic bone pain, notify the provider for regimen review; effective cancer pain control typically pairs an around-the-clock long-acting opioid with a short-acting breakthrough dose of roughly 10-20% of the 24-hour total. RN interventions include medication reconciliation, teaching scheduled versus PRN dosing, safe storage, no sharing, sedation/driving precautions, and nonpharmacologic strategies (positioning, heat/cold when appropriate, relaxation, PT referral).

Always pair scheduled opioids with a stimulant laxative bowel regimen (senna, with or without docusate); bulk/fiber laxatives alone are inadequate and can worsen opioid-induced constipation. The nurse does not independently increase opioid doses beyond orders.

Nutrition Support

Cancer cachexia and treatment effects (mucositis, nausea, diarrhea, early satiety, taste change, dysphagia, depression, financial barriers) erode intake. Trend matters more than a single complaint: unintentional loss >=5% in one month or >=10% over six months meets malnutrition criteria. This patient's 8% two-month loss warrants dietitian referral and provider notification. For metallic taste, teach plastic utensils, cold or room-temperature foods, tart flavors if mucosa is intact, oral care before meals, small frequent high-protein meals, and oral nutrition supplements.

Escalate mucositis, dysphagia, aspiration, uncontrolled nausea, severe diarrhea, or dehydration. Do not blame the patient for not eating; assess barriers and match the intervention to the cause. Document fever details, chemotherapy timing, urgent-evaluation handoff, pain assessment, medication-safety teaching, nutrition risk, referrals, and timed follow-up, and confirm the febrile patient actually reached evaluation.

Numbers, Equianalgesia, and Common Traps

The symptom-management domain rewards exact thresholds. ANC is calculated as total white blood cell count multiplied by the percentage of segmented neutrophils plus bands; an ANC under 500 (or under 100 for profound neutropenia) defines the highest infection risk. Nadir, the lowest count, typically occurs 7-14 days after most chemotherapy, which is when fever calls are most dangerous. Filgrastim (G-CSF) supports neutrophil recovery but is given per order, not as a nurse-initiated fever treatment.

Pain and nutrition anchors:

• Breakthrough opioid dosing is roughly 10-20% of the total 24-hour dose, offered for pain that breaks through scheduled long-acting therapy.
• Opioids have no ceiling dose, but sedation preceding respiratory depression is the key safety sign; naloxone is reserved for true respiratory depression, not routine drowsiness.
• Cancer-related pain is best managed with scheduled dosing for constant pain; PRN-only regimens for constant pain are a common wrong answer.
• Malnutrition criteria: loss of >=5% in one month or >=10% in six months of usual body weight.

Classic traps: telling a febrile post-chemo patient to take acetaminophen and wait (masks fever, delays cultures and antibiotics), recommending bulk fiber alone for opioid-induced constipation (inadequate; needs a stimulant laxative), and treating new back pain with weakness as routine bone pain (it is possible cord compression). On mixed symptom items, treat fever as an emergency, pain as multidimensional and functional, and nutrition as a measurable trend, then confirm teaching with reassessment and caregiver instructions.